$LRSV - News article out a few days ago covers LRSV as currently undervalued. With its tight share structure, selling of shroom product via its 1 subsidiary & pet CBD products via the other wont be shocked to see it much higher in near future
https://equitiesobserver.com/2021/08/18/4-und...potential/